{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:21:24Z","timestamp":1787739684066,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","award":["GZ-2017-11768"],"award-info":[{"award-number":["GZ-2017-11768"]}],"id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK067859"],"award-info":[{"award-number":["R01 DK067859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD098180"],"award-info":[{"award-number":["R01 HD098180"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ymgme.2022.06.006","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T21:18:12Z","timestamp":1656451092000},"page":"296-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A rapid and non-invasive proteomic analysis using DBS and buccal swab for multiplexed second-tier screening of Pompe disease and Mucopolysaccharidosis type I"],"prefix":"10.1016","volume":"136","author":[{"given":"Tong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phi","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remwilyn","family":"Dayuha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna I.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aranjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Khaledi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Houn","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2022.06.006_bb0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2022.06.006_bb0010","first-page":"285","article-title":"Newborn screening for lysosomal storage disorders","volume":"32","author":"Anderson","year":"2018","journal-title":"J. Pediat. Health Care Off. Public. Natl. Assoc. Pediatr. Nurse Assoc. Pract."},{"issue":"2","key":"10.1016\/j.ymgme.2022.06.006_bb0015","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.221739","article-title":"Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases","volume":"132","author":"Marques","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ymgme.2022.06.006_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2022.06.006_bb0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ncl.2014.04.010","article-title":"Pompe disease: literature review and case series","volume":"32","author":"Dasouki","year":"2014","journal-title":"Neurol. Clin."},{"issue":"9646","key":"10.1016\/j.ymgme.2022.06.006_bb0030","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe\u2019s disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.ymgme.2022.06.006_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/cge.13224","article-title":"Worldwide distribution of common IDUA pathogenic variants","volume":"94","author":"Poletto","year":"2018","journal-title":"Clin. Genet."},{"issue":"13","key":"10.1016\/j.ymgme.2022.06.006_bb0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.21037\/atm.2019.04.70","article-title":"Long-term outcome and unmet needs in infantile-onset Pompe disease","volume":"7","author":"Hahn","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"12","key":"10.1016\/j.ymgme.2022.06.006_bb0045","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00115-013-3947-9","article-title":"Diagnosis and therapy of late onset Pompe disease","volume":"84","author":"Sch\u00fcller","year":"2013","journal-title":"Nervenarzt"},{"issue":"2","key":"10.1016\/j.ymgme.2022.06.006_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020189","article-title":"Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement","volume":"11","author":"Hampe","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.ymgme.2022.06.006_bb0055","first-page":"847","article-title":"Precision newborn screening for lysosomal disorders","volume":"20","author":"Minter Baerg","year":"2018","journal-title":"Genet. Med. Off. J. Am. Coll. Med.Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2022.06.006_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int. J. Neonat. Screening"},{"issue":"1","key":"10.1016\/j.ymgme.2022.06.006_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6010002","article-title":"Two-tiered newborn screening with post-analytical tools for pompe disease and mucopolysaccharidosis type I results in performance improvement and future direction","volume":"6","author":"Hall","year":"2020","journal-title":"Int. J. Neonat. Screening"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2022.06.006_bb0070","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1542\/peds.2016-0280D","article-title":"The initial evaluation of patients after positive newborn screening: recommended algorithms leading to a confirmed diagnosis of Pompe disease","volume":"140","author":"Burton","year":"2017","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ymgme.2022.06.006_bb0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymgme.2016.05.015","article-title":"Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry","volume":"118","author":"Elliott","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.06.006_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jpeds.2019.04.027","article-title":"The North Carolina experience with mucopolysaccharidosis type I newborn screening","volume":"211","author":"Taylor","year":"2019","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2022.06.006_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgme.2022.06.006_bb0090","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s10038-019-0603-7","article-title":"Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients","volume":"64","author":"Momosaki","year":"2019","journal-title":"J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2022.06.006_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns6020031","article-title":"Newborn screening for Pompe disease","volume":"6","author":"Sawada","year":"2020","journal-title":"Int. J. Neonat. Screening"},{"key":"10.1016\/j.ymgme.2022.06.006_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jpeds.2016.11.036","article-title":"Mucopolysaccharidosis type I newborn screening: best practices for diagnosis and management","volume":"182","author":"Clarke","year":"2017","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2022.06.006_bb0105","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1373\/clinchem.2016.259036","article-title":"Liquid chromatography-tandem mass spectrometry assay of leukocyte acid \u03b1-glucosidase for post-newborn screening evaluation of Pompe disease","volume":"63","author":"Lin","year":"2017","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.ymgme.2022.06.006_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2012.05.003","article-title":"Biomarkers for the mucopolysaccharidoses: discovery and clinical utility","volume":"106","author":"Clarke","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.06.006_bb0115","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1053\/j.gastro.2021.02.052","article-title":"Direct measurement of ATP7B peptides is highly effective in the diagnosis of Wilson disease","volume":"160","author":"Collins","year":"2021","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.ymgme.2022.06.006_bb0120","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1021\/pr300652v","article-title":"High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry","volume":"11","author":"Razavi","year":"2012","journal-title":"J. Proteome Res."},{"issue":"8","key":"10.1016\/j.ymgme.2022.06.006_bb0125","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1074\/mcp.O115.050351","article-title":"Peptide Immunoaffinity enrichment and targeted mass spectrometry enables multiplex, quantitative pharmacodynamic studies of phospho-signaling","volume":"14","author":"Whiteaker","year":"2015","journal-title":"Mol. Cell. Proteom. MCP"},{"issue":"15","key":"10.1016\/j.ymgme.2022.06.006_bb0130","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1021\/acs.analchem.6b00946","article-title":"Automated microchromatography enables multiplexing of immunoaffinity enrichment of peptides to greater than 150 for targeted MS-based assays","volume":"88","author":"Ippoliti","year":"2016","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2022.06.006_bb0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/clinchem\/hvz022","article-title":"Protein biomarker quantification by immunoaffinity liquid chromatography\u2013tandem mass spectrometry: current state and future vision","volume":"66","author":"Neubert","year":"2020","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2022.06.006_bb0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fimmu.2020.00464","article-title":"Multiplexed proteomic analysis for diagnosis and screening of five primary immunodeficiency disorders from dried blood spots","volume":"11","author":"Collins","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ymgme.2022.06.006_bb0145","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/acs.jproteome.6b00828","article-title":"Quantification of ATP7B protein in dried blood spots by peptide immuno-SRM as a potential screen for Wilson\u2019s disease","volume":"16","author":"Jung","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ymgme.2022.06.006_bb0150","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.3389\/fimmu.2018.02756","article-title":"Rapid multiplexed proteomic screening for primary immunodeficiency disorders from dried blood spots","volume":"9","author":"Collins","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.ymgme.2022.06.006_bb0155","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1053\/j.gastro.2021.02.052","article-title":"Direct measurement of ATP7B peptides is highly effective in the diagnosis of Wilson disease","volume":"160","author":"Collins","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ymgme.2022.06.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2017.91","article-title":"Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer","volume":"4","author":"Song","year":"2017","journal-title":"Scient. Data"},{"key":"10.1016\/j.ymgme.2022.06.006_bb0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clinms.2020.01.001","article-title":"More sensitivity is always better: measuring sub-clinical levels of serum thyroglobulin on a \u03bcLC\u2013MS\/MS system","volume":"15","author":"Shuford","year":"2020","journal-title":"Clin. Mass Spect."},{"issue":"7","key":"10.1016\/j.ymgme.2022.06.006_bb0170","first-page":"966","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"2","key":"10.1016\/j.ymgme.2022.06.006_bb0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","article-title":"Early initiation of enzyme replacement therapy for the mucopolysaccharidoses","volume":"111","author":"Muenzer","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2022.06.006_bb0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymgme.2016.01.011","article-title":"Enzyme replacement therapy prior to haematopoietic stem cell transplantation in mucopolysaccharidosis type I: 10 year combined experience of 2 centres","volume":"117","author":"Ghosh","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2022.06.006_bb0185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-017-0662-9","article-title":"Open issues in mucopolysaccharidosis type I-Hurler","volume":"12","author":"Parini","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2022.06.006_bb0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13052-018-0552-3","article-title":"Newborn screening in mucopolysaccharidoses","volume":"44","author":"Donati","year":"2018","journal-title":"Ital. J. Pediatr."},{"issue":"8","key":"10.1016\/j.ymgme.2022.06.006_bb0195","first-page":"840","article-title":"Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease","volume":"20","author":"Tortorelli","year":"2018","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2022.06.006_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6010010","article-title":"Incorporation of second-tier biomarker testing improves the specificity of newborn screening for mucopolysaccharidosis type I","volume":"6","author":"Peck","year":"2020","journal-title":"Int. J. Neonat. Screening"},{"issue":"3","key":"10.1016\/j.ymgme.2022.06.006_bb0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/ijns6030069","article-title":"Evaluation of multiple methods for quantification of glycosaminoglycan biomarkers in newborn dried blood spots from patients with severe and attenuated mucopolysaccharidosis-I","volume":"6","author":"Herbst","year":"2020","journal-title":"Int. J. Neonat. Screening"},{"issue":"3","key":"10.1016\/j.ymgme.2022.06.006_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6030069","article-title":"Evaluation of multiple methods for quantification of glycosaminoglycan biomarkers in newborn dried blood spots from patients with severe and attenuated mucopolysaccharidosis-I","volume":"6","author":"Herbst","year":"2020","journal-title":"Int. J. Neonat. Screening"},{"issue":"1","key":"10.1016\/j.ymgme.2022.06.006_bb0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","article-title":"Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience","volume":"160c","author":"Bali","year":"2012","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2022.06.006_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6020032","article-title":"Second tier molecular genetic testing in newborn screening for Pompe disease: landscape and challenges","volume":"6","author":"Smith","year":"2020","journal-title":"Int. J. Neonat. Screening"},{"issue":"2","key":"10.1016\/j.ymgme.2022.06.006_bb0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymgme.2013.08.010","article-title":"A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease","volume":"111","author":"Wang","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgme.2022.06.006_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6030065","article-title":"The impact of post-analytical tools on New York screening for Krabbe disease and Pompe disease","volume":"6","author":"Martin","year":"2020","journal-title":"Int. J. Neonat. Screening"},{"issue":"10","key":"10.1016\/j.ymgme.2022.06.006_bb0235","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/clinchem\/43.10.1824","article-title":"On the meaning of \u201csensitivity\u201d","volume":"43","author":"Ekins","year":"1997","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.ymgme.2022.06.006_bb0240","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/clinchem\/47.8.1378","article-title":"Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease","volume":"47","author":"Umapathysivam","year":"2001","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2022.06.006_bb0245","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1038\/s41598-018-25311-0","article-title":"Quantitation of the cellular content of saliva and buccal swab samples","volume":"8","author":"Theda","year":"2018","journal-title":"Sci. Rep."},{"issue":"83","key":"10.1016\/j.ymgme.2022.06.006_bb0250","article-title":"Salivary diagnostics in pediatrics: applicability, translatability, and limitations","volume":"5","author":"Hassaneen","year":"2017","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.ymgme.2022.06.006_bb0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-016-0293-0","article-title":"Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome","volume":"8","author":"Grassl","year":"2016","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.ymgme.2022.06.006_bb0260","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000353721","article-title":"Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants","volume":"104","author":"Murgas Torrazza","year":"2013","journal-title":"Neonatology"},{"issue":"9","key":"10.1016\/j.ymgme.2022.06.006_bb0265","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.bbmt.2018.06.001","article-title":"Salivary \u03b1-iduronidase activity as a potential new biomarker for the diagnosis and monitoring the effect of therapy in mucopolysaccharidosis type I","volume":"24","author":"van Doorn","year":"2018","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"issue":"12","key":"10.1016\/j.ymgme.2022.06.006_bb0270","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1016\/j.ymthe.2021.08.020","article-title":"Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies","volume":"29","author":"Baik","year":"2021","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222003559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222003559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:52:48Z","timestamp":1761090768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719222003559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1096719222003559"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.06.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapid and non-invasive proteomic analysis using DBS and buccal swab for multiplexed second-tier screening of Pompe disease and Mucopolysaccharidosis type I","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}